BMO Capital analyst issues OUTPERFORM recommendation for EMA on February 24, 2026 06:24PM ET. The previous analyst recommendation was Outperform.EMA was trading at $50.625 at issue of the analyst recommendation.The...
TD Securities analyst issues BUY recommendation for EMA on February 24, 2026 06:39PM ET. The previous analyst recommendation was Buy.EMA was trading at $50.62 at issue of the analyst recommendation.The...
Scotiabank analyst issues SECTOR PERFORM recommendation for TECK on February 24, 2026 06:33PM ET. The previous analyst recommendation was Sector Perform.TECK was trading at $60.15 at issue of the analyst...
TD Securities analyst issues BUY recommendation for DALXF on February 24, 2026 06:39PM ET. The previous analyst recommendation was Buy.DALXF was trading at $7.67 at issue of the analyst recommendation.The...
Barclays analyst issues OVERWEIGHT recommendation for IGGHY on February 24, 2026 05:04PM ET. The previous analyst recommendation was Overweight.IGGHY was trading at $20 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for ENLAY on February 24, 2026 05:03PM ET. The previous analyst recommendation was Overweight.ENLAY was trading at $11.55 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for AEOXF on February 24, 2026 05:01PM ET. The previous analyst recommendation was Overweight.AEOXF was trading at $143.428 at issue of the analyst recommendation.The overall...
Barclays analyst issues UNDERWEIGHT recommendation for AFLYY on February 24, 2026 05:02PM ET. The previous analyst recommendation was Underweight.AFLYY was trading at $1.455 at issue of the analyst recommendation.The overall...
Goldman Sachs analyst issues BUY recommendation for BRRLY on February 24, 2026 05:12PM ET. The previous analyst recommendation was Buy.BRRLY was trading at $19.55 at issue of the analyst recommendation.Historical...
Barclays analyst issues OVERWEIGHT recommendation for BIOVF on February 24, 2026 05:09PM ET. The previous analyst recommendation was Overweight.BIOVF was trading at $37 at issue of the analyst recommendation.The overall...
